Squamous Cell Carcinoma of the Anal Canal

• CLINICAL_TRIALS guidance · 2026-01-08
  Clinical Trial Update: An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC)

  This document describes an Early Access Program Guideline to provide access to retifanlimab (INCMGA00012) with carboplatin and paclitaxel fo…

• CLINICAL_TRIALS trial_result · 2025-05-23
  Clinical Trial Update: Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2). [Phase 3]

  Phase 3 POD1UM-303/InterAACT 2 trial evaluating adding retifanlimab to carboplatin-paclitaxel versus placebo in locally advanced or metastat…

• CLINICAL_TRIALS trial_result · 2021-08-23
  Clinical Trial Update: A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202) [Phase 2]

  Phase 2 trial update reporting results for INCMGA00012 in squamous cell carcinoma of the anal canal after platinum-based chemotherapy; study…